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Interaction between Neuronal Depolarization and  
MK-801 in SH-SY5Y Cells and the Rat Cortex 
 
 
 
ObjectiveᄏThe interaction between MK-801, a model of psychosis and KCl-induced 
depolarization or electroconvulsive shock (ECS), a therapeutic model of electroconvulsive 
therapy (ECT), was investigated in SH-SY5Y cells and the rat frontal cortex.   
MethodsᄏSH-SY5Y cells were pretreated with 1  μM MK-801 for 15 min, followed by 
cotreatment with 100 mM KCl for 5 min. MK-801 was reintroduced after the KCl was 
washed out, and the samples were incubated before harvesting. For the experiments in 
rats, male Sprague-Dawley rats were treated with MK-801 followed by ECS. Immunoblot 
analyses of glycogen synthase kinase 3β (GSK3β) (Ser9), AKT (Ser473) and extracel-
lular legulated kinase (ERK)1/2 in SH-SY5Y cells and the rat frontal cortex were performed.
ResultsᄏKCl-induced neuronal depolarization resulted in the transient dephosphoryla-
tion of AKT (Ser473) and GSK3β  (Ser9), followed by increased phosphorylation of the 
enzymes in SH-SY5Y cells. Cotreatment with MK-801 and KCl inhibited the initial de-
phosphorylation of AKT and GSK3β produced by KCl-induced neuronal depolarization. 
Similarly, ECS resulted in the transient dephosphorylation of AKT (Ser473) and GSK3β 
(Ser9), whereas cotreatment with MK-801 inhibited the initial dephosphorylation of AKT 
(Ser473) and GSK3β (Ser9) produced by ECS in the rat frontal cortex. No significant 
interaction was observed between MK-801 and KCl in the dephosphorylation of ERK1/2. 
ConclusionᄏThese results suggest that an antagonistic interplay between MK-801 and 
neuronal depolarization by KCl or ECS is involved the regulation of AKT (Ser473) and 
GSK3β  (Ser9) phosphorylation. 
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Introduction 
 
Intracellular signal interference may play a substantial role in the development of
neuropathological processes in psychosis, thus the elimination of the cause of the
interference may be a potential target in the treatment of psychosis. Complex arrays
of intracellular signal transduction pathways lead to changes in cellular function. To
determine the relationship between pathological processes and recovery mechanisms,
it is necessary to clarify the effects of the interaction between pathogenic and therapeutic
stimuli on intracellular signal transduction pathways.
1 Of the many signaling pathways
implicated in neuronal function, the mitogen-activated protein kinase (MAPK) and 
AKT-glycogen synthase kinase 3β (AKT-GSK3β) pathways have been widely in-
vestigated.
2,3 These pathways are reported to play important roles in both the patho-
genesis and therapeutic mechanism associated with the treatment of various psychoses,
such as schizophrenia and bipolar disorders.
4-7  
 MK-801 is a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist 
that is commonly used to induce a psychosis-like state that is characterized by both 
negative and positive symptoms of schizophrenia. Rodents treated with MK-801 dis-
played psychotomimetic behavior and behaviors that correspond to the core symptoms 
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of psychosis.
8 Single administration of MK-801 may also 
result in acute behavioral effects,
9 whereas prolonged ad-
ministration of MK-801 has been shown to induce be-
havioral effects consistent with the cognitive deficits and 
negative symptoms of schizophrenia.
10 We previously 
reported that MK-801 increased the phosphorylation of 
GSK-3β (Ser9), AKT (Ser473) and cyclic adenosine 
monophosphate-responsive element binding (CREB)(Ser 
133) in the rat brain.
11 We also reported that treatment with 
1 mg/kg MK-801 resulted in the upregulation of phosph-
orylation in the mitogen-activated ERK kinase (MEK)-
ERK-p90RSK pathways in the rat frontal cortex.
12 
Electroconvulsive therapy (ECT) has been proven to 
be very effective in managing psychotic or depressive 
symptoms that respond poorly to pharmacotherapy.
13 
Electroconvulsive shock (ECS), which is often used as 
a model for ECT in humans, has been found to increase 
neurogenesis in the rat hippocampus and activate cell 
cycle-dependent kinases in the rat frontal cortex.
14,15 ECS 
causes massive neuronal depolarization, which triggers 
rapid signaling in the nervous system via synaptic trans-
mission and axonal conductance.
16 KCl-induced neuronal 
depolarization is widely used as an in vitro model of 
neuronal activity and ECS.
17 It was previously reported 
that acute ECS could cause biphasic changes in the ph-
osphorylation of GSK-3β (Ser9) in the rat brain.
18 In 
addition, multiple ECS treatment was reported to affect 
the expression and phosphorylation of ERK1/2 in the rat 
frontal cortex.
19 There were also reports that KCl-in-
duced depolarization causes a biphasic temporal pattern 
of AKT (Ser473) and GSK3β (Ser9) phosphorylation in 
SH-SY5Y cells17 and induces neuronal proliferation.
20 
To better understand the interplay between the signal-
ing pathways involved in the pathogenesis and therapeutic 
mechanisms, we tried to explore the possibility of a 
cellular model. Thus, we investigated the interaction be-
tween MK801, a model of psychosis, and KCl-induced 
depolarization, a therapeutic model of ECT in SH-SY5Y 
human neuroblastoma cells. The aim of this study was 
to analyze the interaction between MK-801 and KCl-
induced depolarization and investigate its role in the 
regulation of AKT-GSK3β and ERK1/2 in SH-SY5Y 
cells. The second aim of this study was to investigate 
whether the interactions observed in these cell lines were 
reproducible in the rat frontal cortex after MK801 treat-
ment followed by ECS. 
 
Methods 
 
Cell culture and treatments 
SH-SY5Y cells were purchased from American Type 
Culture Collection (Manassas, VA, USA). SH-SY5Y cells 
were maintained in Dulbecco’s modified Eagle’s medium 
(DMEM, Sigma-Aldrich, St. Louis, MO, USA) contain-
ing 10% fetal bovine serum (FBS, JBI, Korea) and 100 
U/ml penicillin/streptomycin (Sigma-Aldrich) and in-
cubated at 37℃ in 5% CO2·KCl and NaCl (Sigma-
Aldrich) were dissolved in DMEM. MK-801 (Tocris, 
Bristol, UK) was dissolved in normal saline. Before 
treatment, SH-SY5Y cells were washed and incubated 
overnight in fresh DMEM containing 10% FBS. Neu-
ronal depolarization was induced by treating the cells 
with 100 mM KCl in complete medium for 5 min. The 
cells were then immediately washed with fresh medium 
and reintroduced into fresh medium. For treatment with 
MK-801, 1  μM MK-801 was added, and the cells were 
incubated for 15 min, after which the medium was re-
placed with fresh medium containing 1 μM MK-801. 
The dissociation value (KD) of MK-801 was 5.7 nM for 
the whole brain and 8.1 nM for the spinal cord.
21 MK-
801 was used at a concentration of 1 μM in order to 
completely block the NMDA receptor, while minimiz-
ing the direct osmotic and physically toxic effect on SH-
SY5Y cells. Post-treatment, the cells were harvested after 
incubation in fresh medium for the indicated times. 
 
Animal treatments 
Animals were treated in accordance with the Guide 
for the Care and Use of Laboratory Animals published 
by the National Institutes of Health (NIH). Male Spra-
gue-Dawley rats (150-200 g) were housed for 2 weeks 
before the experiment and maintained under 12 h light/ 
12 h dark conditions with food and water available ad 
libitum. The rats were divided into three groups of three 
each. The groups were given the following treatments: 
group 1, intraperitoneal injection of normal saline follow-
ed by sham treatment; group 2 intraperitoneal injection 
of normal saline followed by a single ECS; and group 3, 
intraperitoneal injection of 1 mg/kg MK-801, followed 
by a single ECS. Previous experiments have shown that 
AKT and GSK phosphorylation increased after treatment 
with MK-801 at concentrations up to 1 mg/kg in the rat 
frontal cortex but decreased at higher dosages.
11 Therefore, 
1 mg/kg MK-801 was selected in order to achieve max-
imum changes in the phosphorylation of AKT and GSK. 
ECS was delivered to male Sprague-Dawley rats (150-
200 g) via ear-clip electrodes (130 V, 0.5 s, Medicraft B-
24 apparatus). Rats were intraperitoneally injected with 
MK-801 or normal saline 30 min before ECS. Rats were 
sacrificed by decapitation at the indicated time points follow-
ing each treatment, and the frontal cortices were dissected. 
 
Immunoblot analysis 
SH-SY5Y cells were harvested with a cell scraper in  
 
 
 
 
Interaction between Neuronal Depolarization and MK-801 
96 Psychiatry Invest 2008;5:94-101 
lysis buffer containing 25 mM HEPES (pH 7.4), 150 
mM NaCl, 0.1 mM EDTA, 1 mM Na3VO4, 1 mM NaF, 
20 mM β-glycerophosphate, 1 mM phenylmethylsulfonyl 
fluoride, a protease inhibitor mixture (Roche Molecular 
Biochemicals), and 1% Triton X-100. The cells were 
lysed by incubating the suspension on ice for 30 min. 
Rat cortical tissue was homogenized in 10 v/w of ice-
cold homogenization buffer [50 mM Tris, pH 7.4, 1% 
Triton X-100, 0.5% deoxycholate, 150 mM NaCl, 1 mM 
EGTA, 1 mM EDTA, 1 mM Na3VO4, Complete Mini 
Protease Inhibitor Cocktail (Roche Diagnostics, Switz-
erland), 1 mM DTT, 1 mM PMSF]. Homogenates were 
centrifuged, and supernatants were boiled with Laemmli’s 
sample buffer. The samples were then separated by 
SDS-PAGE.  
Antibodies against GSK3β, ERK1/2 were purchased 
from Santa Cruz Biotechnology (1：5000; Santa Cruz, 
CA, USA), and antibodies against phosphorylated GSK3
β (1：1000, Ser9), phosphorylated AKT (1：1000, 
Ser473), phosphorylated ERK1/2 (1：1500, Thr202/ 
Tyr204) and AKT (1：3000) were obtained from New 
England BioLab’s Cell Signaling Group (Beverly, MA, 
USA). Horseradish peroxidase-conjugated goat anti-
mouse and goat anti-rabbit IgG antibodies (1 : 3000) were 
obtained from Zymed (San Francisco, CA, USA). The 
blots were incubated with enhanced chemiluminescence 
substrate mix (Pierce, Rockford, IL, USA) and exposed 
to radiographic film (AGFA, Curix RPI, Mortsel, Bel-
gium) in order to obtain images. The densities of the bands 
were quantified using an image analyzer (TINA 2.0, 
Raytest, Germany).  
 
Statistical analysis 
All analyses were performed using SPSS 13.0 for 
Windows (SPSS Inc., Chicago, IL, USA), and the data 
are presented as the means±S.D. The nonparametric 
Mann-Whitney U test was used for non-normal data to 
analyze mean values, and statistical significance was 
established at p<0.05 (two-tailed). 
 
Results 
 
Phosphorylation of AKT at Ser473 in SH-SY5Y 
cells 
The phosphorylation of AKT (Ser473) was signifi-
cantly decreased at 0 min after the cells were treated 
with 100 mM KCl for 5 min (70.3±14.1% of control 
value; Mann-Whitney test: t =10.00, z=-2.460, p= 
0.007, r=-0.87; n=4). The phosphorylation of AKT 
(Ser473) increased between 5 and 30 min after the in-
itial dephosphorylation, peaked at 15 min, and then 
returned to baseline at 60 min. No significant changes in 
the phosphorylation of AKT (Ser473) were observed 
after treatment with MK-801 alone, though some fluc-
tuations were observed. When the cells were treated 
with KCl and MK-801, the phosphorylation of AKT 
(Ser473) showed a pattern of change similar to that ob-
served after treatment with KCl alone, except that no 
immediate dephosphorylation was observed at 0 min 
(94.0±14.5% of control value; n=4). There was a sig-
nificant difference in phosphorylation at 0 min between 
the KCl-treated cells and the MK-801- and KCl-treated 
cells (Mann-Whitney test: t=10.00, z=-1.732, p=0.042, 
r=-0.61; n=4), indicating that MK-801 blocked the 
KCl-induced dephosphorylation of AKT (Ser473) at 0 
min. The total amount of AKT did not change signifi-
cantly under any of the conditions (Figure 1A). 
 
Phosphorylation of glycogen synthase kinase 3β 
at Ser9 in SH-SY5Y-cells 
GSK3β (Ser9) phosphorylation was decreased at 0 
min after KCl treatment, as compared with the vehicle-
treated controls (74.1±26.2% of control value; Mann-
Whitney test: t=10.00, z=-2.460, p=0.007, r=-0.87; 
FIGURE 1. Effects of KCl-induced depolarization and MK-801 on 
the phosphorylation of AKT (Ser473), GSK3β (Ser9) and ERK1/2 
(Thr202/Tyr204). For the interaction experiment, cells were pre-
treated with 1 μM MK-801 for 15 min, followed by cotreatment 
with 100 mM KCl for 5 min. After the KCl was washed out, MK-
801 was reintroduced, and the samples were incubated for the 
indicated times before harvesting. Representative immunoblots of 
phosphorylation of (A) AKT (Ser473), (B) GSK3β (Ser9) and (C)
ERK1/2  (Thr202/Tyr204) in SH-SY5Y cells harvested after ex-
posure to 100 mM KCl-induced depolarization, 1 μM MK-801, 
and KCl plus MK-801 cotreatment for the indicated times are 
shown. C indicates the vehicle-treated controls. GSK3β: glycogen 
synthase kinase 3β, ERK:  extracellular legulated kinase.  
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n=4), and then increased slightly before returning to a 
basal level. The phosphorylation of GSK3β (Ser9) also 
decreased at 0 min after MK-801 treatment and recover-
ed slowly to a basal level at 30-60 min. After treatment 
with KCl and MK-801, the phosphorylation of GSK3β 
(Ser9) showed a pattern of change similar to that ob-
served after treatment with KCl alone, except that no 
immediate dephosphorylation was observed at 0 min 
(121.3±32.6% of control value). There was a signifi-
cant difference in phosphorylation at 0 min between cells 
treated with KCl alone and those treated with MK-801 
and KCl (Mann-Whitney test: t=10.00, z=-1.732, p= 
0.042, r=-0.61; n=4). The total amount of GSK3β 
did not change significantly under any of the conditions 
(Figure 1B). 
Phosphorylation of extracellular legulated kinase 
1/2 at Thr202/Tyr204 in SH-SY5Y cells 
The phosphorylation of ERK1/2 at Thr202/Tyr204 was 
decreased to below basal level at 0 min after treatment 
with KCl alone (29.3±30.0% of control value; Mann-
Whitney test: t=10.00, z=-2.460, p=0.007, r=-0.87; 
n=4), peaked at 15 min, and then returned to baseline 
at 60 min. After treatment with MK-801 alone, the phos-
phorylation of ERK1/2 (Thr202/Tyr204) was decreased 
at 0 min (63.5±19.6% of control value; Mann-Whitney 
test: t=10.00, z=-2.460, p=0.007, r=-0.87; n=4) and 
then slowly recovered to basal level between 5-60 min. 
After cotreatment with both KCl and MK-801, the 
phosphorylation of ERK1/2 (Thr202/Tyr204) showed a 
pattern of change similar to that observed after treatment 
FIGURE 2. Effects of KCl and NaCl on the phosphorylation of AKT (Ser473), GSK3β (Ser9), and ERK1/2 (Thr202/Tyr204) in SH-SY5Y 
cells. Representative immunoblot of changes in the phosphorylation of (A) AKT (Ser473), (B) GSK3β (Ser9), and (C) ERK1/2 (Thr202/ 
Tyr204). After SH-SY5Y cells were treated with 100 mM KCl or NaCl in complete medium for 5 min, the cells were washed and harvested
for analysis. The quantitative analysis of the phosphorylation is presented in the bar graphs. The amount of phosphorylation is expressed as
a percentage of the corresponding density of the vehicle-treated controls. The graphs represent the average values and standard devia-
tions. The asterisk (*) indicates a statistically significant difference in GSK3β phosphorylation compared with the vehicle-treated controls 
(Mann-Whitney test: t=10.00, z=-2.460, p=0.014, r=-0.87; n=4). C indicates vehicle-treated controls. GSK3β: glycogen synthase kinase 
3β, ERK:  extracellular legulated kinase. 
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with KCl alone, exhibiting dephosphorylation at 0 min 
(49.0±29.6% of control value; Mann-Whitney test: t= 
10.00, z=-2.460, p=0.007, r=-0.87; n=4). The total 
amount of ERK1/2 did not change significantly under 
any of the conditions (Figure 1C). 
 
Effects of KCl and NaCl on SH-SY5Y cells 
The depolarizing and osmotic effects of KCl were 
evaluated. SH-SY5Y cells were treated with 100 mM of 
KCl or NaCl for 5 min, and the effects of these treatments 
on the phosphorylation of AKT (Ser473), GSK3β 
(Ser9), and ERK1/2 (Thr202/Tyr204) were compared. 
The phosphorylation of AKT (Ser473) was decreased 
in cells treated with KCl in comparison with the vehicle-
treated controls (77.6±15.3% of control value; n=4), 
but unchanged in cells treated with NaCl (98.8±25.2% 
of control value; n=4, Figure 2A). Although treatment 
with KCl or NaCl, both decreased GSK3β (Ser9) phos-
phorylation (KCl, 43.4±16.6% of control value; NaCl, 
75.2±32.4% of control value; n=4, respectively), the 
KCl treatment was more consistent and effective than 
the NaCl treatment. Treatment with KCl resulted in a 
statistically significant decrease in GSK3β (Ser9) phos-
phorylation in comparison with the controls (Mann-
Whitney test: t=10.00, z=-2.460, p=0.014, r=-0.87; 
n=4, Figure 2B). These findings indicate that both de-
polarization and osmosis contribute to the KCl-induced 
dephosphorylation of GSK3β (Ser9). KCl and NaCl 
each induced a similar decrease in the phosphorylation 
of ERK1/2 (Thr202/Tyr204)(KCl: 29.6±12.6% of con-
trol value; NaCl: 35.1±16.2% of control value; n=3, 
respectively), which suggests that osmotic effects may 
have contributed significantly to the dephosphorylation 
of ERK1/2 (Thr202/Tyr204) by KCl (Figure 2C). 
 
Phosphorylation of AKT at Ser473 in the rat fron-
tal cortex 
The phosphorylation of AKT (Ser473) was decreased 
at 0 and 5 min in the frontal cortex of saline-ECS-treated 
rats in comparison to saline-sham-treated rats (Mann-
Whitney test: 0 min and 5 min respectively, t=6.00, z= 
-2.087, p=0.019, r=-1.21; n=3). After the initial de-
phosphorylation, the phosphorylation of AKT (Ser473) 
showed a tendency to increase and then return to base-
line around 30 min in the frontal cortex of saline-ECS-
treated rats. In MK-801-ECS-treated animals, the phos-
phorylation of AKT (Ser473) was increased at 0 min in 
comparison to the saline-sham-treated samples, and it 
remained increased until 30 minutes after ECS, with sta-
tistical significance at 0 min and 10 min (Mann-Whitney 
test: 0 min and 10 min respectively, t=6.00, z=-2.087, 
p=0.019, r=-1.21; n=3). At 0 and 5 min after ECS, 
the phosphorylation of AKT at Ser 473 was af-fected by 
pretreatment with either saline or MK-801 (Mann-Whit-
ney test: 0 min and 5 min respectively, t= 6.00, z=-1.964, 
p=0.025, r=-1.14; n=3). There was no difference be-
tween the saline-ECS- and MK-801-ECS-treated groups 
at 10 or 30 min after ECS (Figure 3A). 
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FIGURE 3. Effects of MK-801 and electroconvulsive shock on the
phosphorylation of AKT (Ser473) and GSK3β (Ser9) in the rat 
frontal cortex. Representative immunoblots of (A) AKT (Ser473)
and (B) GSK3β (Ser9) phosphorylation in the rat frontal cortex
after intraperitoneal (IP) injection of saline followed by electrocon-
vulsive shock (ECS) or after IP injection of 1 mg/kg MK-801 fol-
lowed by ECS. Densitometric analysis of AKT (Ser473) phosphory-
lation at designated time points after saline-ECS or MK-801-ECS 
treatment is presented in the bar graphs. The amount of pho-
sphorylated AKT (Ser473) or GSK3β (Ser9) is expressed as a
percentage of the corresponding density of the saline-sham-treated 
controls (S). The data represent the average values and standard
deviations of three independent experiments. A nonspecific band
(n.s.) is given to show that an equal amount of protein was ap-
plied to each lane of the immunoblot. The asterisk (*) indicates 
statistically significant difference in phosphorylation from that of
the saline-sham-treated controls (Mann-Whitney test: t=6.00, z= 
-2.087, p=0.019, r=-1.21, n=3). The double asterisk (**) indicates
statistically significant difference in phosphorylation between the
saline-ECS-treated group and the MK-801-ECS-treated group
(Mann-Whitney test: t=6.00, z=-1.964, p=0.025, r=-1.14; n=3). 
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creased at 0 min in the frontal cortex of saline-ECS-
treated rats in comparison to saline-sham-treated rats 
(Mann-Whitney test: t=6.00, z=-2.087, p=0.019, r= 
-1.21; n=3). After the initial dephosphorylation, the 
phosphorylation of GSK3β (Ser9) increased and then 
returned to baseline after approximately 30 min in the 
saline-ECS-treated rat frontal cortex. In the MK-801-
ECS-treated animals, the phosphorylation of GSK3β 
(Ser9) was increased at 0 min in comparison to the 
saline-sham-treated samples, remained increased until 
10 min after ECS and then returned to baseline at 30 
minutes after ECS (Mann-Whitney test: 0 min, 5 min and 
10 min respectively t=6.00, z=-2.087, p=0.019, r= 
-1.21; n=3). At 0 min after ECS, phosphorylation of 
GSK3β (Ser9) was affected by pretreatment with either 
saline or MK-801 (Mann-Whitney test: 0 min, t=6.00, 
z=-1.964, p=0.025, r=-1.14; n=3). There was no dif-
ference between the saline-ECS-treated and MK-801-
ECS-treated groups at 5,10 or 30 min after ECS (Figure 
3B). 
 
Discussion 
 
In this study, the interaction between MK-801 and 
KCl-induced depolarization and its role in the regulation 
of AKT-GSK3β and ERK1/2 in SH-SY5Y cells were 
investigated. We found that MK-801 inhibited the im-
mediate KCl-induced dephosphorylation of AKT (Ser473) 
and GSK3β (Ser9) in SH-SY5Y neuroblastoma cells. 
MK-801 had no effect on the KCl-induced immediate 
dephosphorylation of ERK1/2 (Thr202/Tyr204). We also 
observed that ECS resulted in immediate transient de-
phosphorylation of AKT (Ser473) and GSK3β (Ser9), 
whereas pretreatment with MK-801 inhibited the im-
mediate dephosphorylation of AKT (Ser473) and GSK3β 
(Ser9) produced by ECS in the rat frontal cortex. These 
findings suggest that the AKT-GSK3β pathway may 
be involved in the antagonistic interplay between MK-
801 and KCl-induced depolarization/ECS.   
A primary effect of KCl is to induce intracellular Ca
2+ 
flow via VGCC, whereas a primary effect of MK-801 is 
to block the flow of intracellular Ca
2+ via the NMDA 
receptor.
17,22 Therefore, it is plausible that MK-801 may 
inhibit the KCl-induced dephosphorylation of AKT 
(Ser473) and GSK3β (Ser9) in a calcium-dependent 
manner. There have also been reports of increased phos-
phatase activity and reduced phosphorylation of AKT 
(Ser473) and GSK3β (Ser9) immediately after ECS 
treatment.
23 Decreases in basal Ca
2+ influx caused by 
MK-801 may inhibit the KCl-induced activation of pho-
sphatases, which may result in the inhibition of depho-
sphorylation of AKT (Ser473) and GSK3β (Ser9). 
The time series changes in the phosphorylation of 
AKT (Ser473) and GSK3β (Ser9) after treatment with 
MK-801 were previously reported by the authors and 
are therefore not shown in this study.
11 We previously 
reported that the phosphorylation of AKT (Ser473) and 
GSK3β (Ser9) were increased in the rat frontal cortex 
at 15-90 minutes after treatment with MK-801.
11 There-
fore, although treatment with MK-801 alone did not result 
in a statistically significant increase in the phosphoryl-
ation of AKT (Ser473) or GSK3β (Ser9) in SH-SY5Y 
cells (Figure 1B), it is possible that an increase in the 
phosphorylation of AKT (Ser473) and GSK3β (Ser9) 
by MK-801 may have overcome the dephosphorylation 
induced by KCl. 
Moreover, we found that, for AKT (Ser473) and 
GSK3β (Ser9), the interaction between ECS and MK-
801 in the rat frontal cortex was similar to the interac-
tion between KCl-induced depolarization and MK-801 
in SH-SY5Y cells. These findings also suggest that the 
depolarizing effect of KCl may share a similar mechanism 
with the immediate response of ECS. In addition, the 
similarity in the findings in SH-SY5Y neuroblastoma cells 
and rat frontal cortex suggests the possibility of using 
SH-SY5Y as a cellular model for investigating the me-
chanism of interaction between MK-801 and ECS in future 
studies.  
Our result also indicated that there is no significant 
interaction between MK-801 and KCl related to the de-
phosphorylation of ERK1/2. Furthermore, the dephospho-
rylation of ERK1/2 (Thr202/Tyr204) was not caused by 
the depolarizing effect of KCl but rather by its osmotic 
effect because the effect of NaCl was similar to that of 
KCl. Our findings show that the depolarizing effect of 
KCl contributes to the dephosphorylation of AKT and 
GSK3β and that the osmotic effect of KCl contributes 
to the dephosphorylation of ERK1/2 (Thr202/Tyr204). 
These findings are consistent with previous reports dem-
onstrating that ECS, which is said to result in massive 
transient depolarization of neurons,
16 caused an immediate 
decrease in the phosphorylation of AKT and GSK3β, 
whereas an immediate increase in the phosphorylation 
of ERK1/2 (Thr202/Tyr204) was observed after ECS.
23 
ERK1/2 has been found to be activated by glutamate 
receptor stimulation and deactivated by NMDA receptor 
antagonists, including MK-801, in primary cortical cul-
tures.
24,25 The results of this study also show that MK-
801 treatment decreased the activation of ERK1/2 in SH-
SY5Y cells. Because we performed the cell experiment 
in whole medium containing 5% serum in order to mimic 
the physiological conditions in the brain, the decrease in 
the activation of ERK1/2 may have resulted from block-
age of the basal level of NMDA receptor activation in  
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SH-SY5Y cells. However, we failed to observe that MK-
801 blocks the initial dephosphorylation of ERK1/2 or sig-
nificantly reduces the KCl-induced activation of ERK1/2 
at later time points. 
The roles of AKT-GSK3β and ERK1/2 in psychiatric 
disorders have been discussed in numerous reports on 
bipolar disorder and schizophrenia.
5,6,26,27 Many reports 
have implicated that the same pathway is involved in 
the therapeutic mechanisms of various mood stabilizers, 
anti-psychotics and ECT.
28-31 This study provides further 
evidence for the above implications by demonstrating 
that AKT-GSK3β and ERK1/2 are regulated by KCl-
induced depolarization, a possible therapeutic model of 
ECS and neuronal activity, and by MK-801, a drug that 
induces psychotomimetic effects. The results of this study 
also show that an antagonistic interplay between MK-
801 and KCl-induced neuronal depolarization may be 
involved in the regulation of AKT (Ser473) and GSK3β 
(Ser9). These molecular interactions may suggest a pos-
sible therapeutic mechanism of ECS in the treatment of 
psychosis. However, the physiological and clinical rele-
vance of these findings need to be further elucidated. 
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